LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA) Fast Track...

BiomX Announces Dosing of First Subject in Phase 1a Study of BX002 Phage Therapy for Inflammatory Bowel Disease Ness Ziona, Israel – Nov....

Phase 1 Clinical Study will Evaluate ADI-001 Safety and Efficacy in Patients with B-cell non-Hodgkin’s lymphoma MENLO PARK, Calif. and...

Orasis Advances Presbyopia Candidate to Phase 3 Clinical Trials HERZLIYA, Israel, September 10, 2020 – Orasis Pharmaceuticals, an...

Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101 for the treatment of Recurrent/Metastatic...